Medizone International, Inc. (MZEI.PK): Trials of the AsepticSure Hospital Sterilization System ... ( SAN FRANCISCO May 6 /- Medizone (Pink...)

Medizone International, Inc. (MZEI.PK): Trials of the AsepticSure Hospital Sterilization System Have Begun

Date:5/6/2009

SAN FRANCISCO, May 6 /PRNewswire-FirstCall/ -- Medizone (Pink Sheets: MZEI) is pleased to announce the commencement of the first in a series of trials designed to confirm that the Medizone AsepticSure(TM) Hospital Sterilization System can rapidly eliminate hospital-based bacterial pathogens known to be responsible for the growing number of deaths and serious infections currently plaguing the healthcare system world wide. Dr. Dick Zoutman, an internationally recognized expert in Medical Microbiology and hospital infections, is leading these trials. Medizone International's Director of Medical Affairs, Dr. Michael E. Shannon observed, "This is an exciting time for our medical engineering group. The equipment is superbly designed with full computer control of all test parameters and hence, we are confident that the entire series of studies will be GLP compliant. If these trials successfully demonstrate that our equipment and protocols are fully effective at eliminating the bacteria being tested, as we anticipate, the results will constitute a powerful signal to the health care community that a safe and inexpensive solution will soon be available to effectively address a problem which last year resulted in over 60,000 hospital acquired infectious disease deaths in North America alone."

"This project," added Dr. Zoutman, "has the potential of saving thousands of lives and hundreds of millions of dollars for hospital operating systems." Medizone expects to release the results of these first trials in June, following the filing of new patent applications.

Medizone International, Inc. is a research and development company engaged in developing its AsepticSuretechnology to decontaminate and sterilize hospital surgical suites, emergency rooms, intensive care units, schools and other critical infrastructure. If current trials continue to proceed successfully they will be followed by a hospital mock-up and then hospital beta testi
'/>"/>

SOURCE Medizone International, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine technology :

1. Arno Therapeutics, Inc. Completes $18 Million Financing and Reverse Merger with Laurier International, Inc.
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
4. PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials
5. Multiple NIH Phase 2 HIV Vaccine Trials Using Vicals Technology Produce Encouraging Results
6. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
7. Sunesis Pharmaceuticals Commences Clinical Trials of SNS-595 and SNS-314
8. ECLIPSE Data on Effects of Otsukas Investigational Novel Treatment, Tolvaptan, on Advanced Heart Failure Patients Hemodynamics and Urine Output Featured in Heart Failure Society of Americas Late Breaking Trials
9. Biodel Inc. Expands Ongoing Phase III VIAject(TM) Clinical Trials Into Europe
10. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
11. Velcura Therapeutics, Inc. Reports Positive Pre-IND Meeting With FDA and Plans Early Clinical Trials for New Drug to Treat Multiple Myeloma Bone Disease

Post Your Comments:

Medizone International, Inc. (MZEI.PK): Trials of the AsepticSure Hospital Sterilization System ...( SAN FRANCISCO May 6 /- Medizone (Pink...),Health